MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with T

Tranexamic acid

Tranexamic acid 500mg tablets

Compatible

Stability notes for Tranexamic acid 500mg tablets

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Cyklokapron 500mg tablets (Viatris UK Healthcare Ltd).

Suppliers (11) of Tranexamic acid 500mg tablets
Evana Heavy Period Relief 500mg tablets (Maxwellia Ltd)
Tranexamic acid 500mg tablets (A A H Pharmaceuticals Ltd)
Tranexamic acid 500mg tablets (Alliance Healthcare (Distribution) Ltd)
Tranexamic acid 500mg tablets (Almus Pharmaceuticals Ltd)
Tranexamic acid 500mg tablets (Manx Healthcare Ltd)
Tranexamic acid 500mg tablets (Medihealth (Northern) Ltd)
Tranexamic acid 500mg tablets (Phoenix Healthcare Distribution Ltd)
Tranexamic acid 500mg tablets (Rivopharm (UK) Ltd)
Tranexamic acid 500mg tablets (Sigma Pharmaceuticals Plc)
Tranexamic acid 500mg tablets (Sovereign Medical Ltd)
Tranexamic acid 500mg tablets (Tillomed Laboratories Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.